J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holtappels, R.
Right arrow Articles by Reddehase, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holtappels, R.
Right arrow Articles by Reddehase, M. J.
Agricola
Right arrow Articles by Holtappels, R.
Right arrow Articles by Reddehase, M. J.
Journal of General Virology (2000), 81, 3037-3042.
© 2000 Society for General Microbiology

Animal: DNA Viruses

Identification of a Kd-restricted antigenic peptide encoded by murine cytomegalovirus early gene M84

Rafaela Holtappels1, Doris Thomas1 and Matthias J. Reddehase1

Institute for Virology, Johannes Gutenberg University, Hochhaus am Augustusplatz, 55101 Mainz, Germany1

Author for correspondence: Matthias Reddehase. Fax +49 6131 39 35604. e-mail Matthias.Reddehase{at}uni-mainz.de

The two sister cytomegaloviruses (CMVs), human and murine CMV, have both evolved immune evasion functions that interfere with the major histocompatibility complex class I (MHC-I) pathway of antigen processing and presentation and are effectual in the early (E) phase of virus gene expression. However, studies on murine CMV have shown that E-phase immune evasion is leaky. An E-phase protein involved in immune evasion, namely m04-gp34, was found to simultaneously account for an antigenic peptide presented by the MHC-I molecule Dd. Recent work has demonstrated the induction of protective immunity specific for the E-phase protein M84-p65, one of two murine CMV homologues of the human CMV matrix protein UL83-pp65. In this study, the identification of the MHC-I Kd-restricted M84 peptide 297AYAGLFTPL305 is documented. This peptide is the third antigenic peptide described for murine CMV and the second that escapes immunosubversive mechanisms.




This article has been cited by other articles:


Home page
 J. Virol.Home page
C. S. Morello, L. A. Kelley, M. W. Munks, A. B. Hill, and D. H. Spector
DNA Immunization Using Highly Conserved Murine Cytomegalovirus Genes Encoding Homologs of Human Cytomegalovirus UL54 (DNA Polymerase) and UL105 (Helicase) Elicits Strong CD8 T-Cell Responses and Is Protective against Systemic Challenge
J. Virol., July 15, 2007; 81(14): 7766 - 7775.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
A. J. Corbett, C. A. Forbes, D. Moro, and A. A. Scalzo
Extensive sequence variation exists among isolates of murine cytomegalovirus within members of the m02 family of genes
J. Gen. Virol., March 1, 2007; 88(3): 758 - 769.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. W. Munks, K. S. Cho, A. K. Pinto, S. Sierro, P. Klenerman, and A. B. Hill
Four Distinct Patterns of Memory CD8 T Cell Responses to Chronic Murine Cytomegalovirus Infection
J. Immunol., July 1, 2006; 177(1): 450 - 458.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M.-F. Pahl-Seibert, M. Juelch, J. Podlech, D. Thomas, P. Deegen, M. J. Reddehase, and R. Holtappels
Highly Protective In Vivo Function of Cytomegalovirus IE1 Epitope-Specific Memory CD8 T Cells Purified by T-Cell Receptor-Based Cell Sorting
J. Virol., May 1, 2005; 79(9): 5400 - 5413.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. S. Morello, M. Ye, S. Hung, L. A. Kelley, and D. H. Spector
Systemic Priming-Boosting Immunization with a Trivalent Plasmid DNA and Inactivated Murine Cytomegalovirus (MCMV) Vaccine Provides Long-Term Protection against Viral Replication following Systemic or Mucosal MCMV Challenge
J. Virol., January 1, 2005; 79(1): 159 - 175.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Ye, C. S. Morello, and D. H. Spector
Multiple Epitopes in the Murine Cytomegalovirus Early Gene Product M84 Are Efficiently Presented in Infected Primary Macrophages and Contribute to Strong CD8+-T-Lymphocyte Responses and Protection following DNA Immunization
J. Virol., October 15, 2004; 78(20): 11233 - 11245.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. Karrer, S. Sierro, M. Wagner, A. Oxenius, H. Hengel, U. H. Koszinowski, R. E. Phillips, and P. Klenerman
Memory Inflation: Continuous Accumulation of Antiviral CD8+ T Cells Over Time
J. Immunol., February 15, 2003; 170(4): 2022 - 2029.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. C. Gold, M. W. Munks, M. Wagner, U. H. Koszinowski, A. B. Hill, and S. P. Fling
The Murine Cytomegalovirus Immunomodulatory Gene m152 Prevents Recognition of Infected Cells by M45-Specific CTL But Does Not Alter the Immunodominance of the M45-Specific CD8 T Cell Response In Vivo
J. Immunol., July 1, 2002; 169(1): 359 - 365.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Holtappels, N. K. A. Grzimek, C. O. Simon, D. Thomas, D. Dreis, and M. J. Reddehase
Processing and Presentation of Murine Cytomegalovirus pORFm164-Derived Peptide in Fibroblasts in the Face of All Viral Immunosubversive Early Gene Functions
J. Virol., May 13, 2002; 76(12): 6044 - 6053.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. S. Morello, M. Ye, and D. H. Spector
Development of a Vaccine against Murine Cytomegalovirus (MCMV), Consisting of Plasmid DNA and Formalin-Inactivated MCMV, That Provides Long-Term, Complete Protection against Viral Replication
J. Virol., April 16, 2002; 76(10): 4822 - 4835.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Ye, C. S. Morello, and D. H. Spector
Strong CD8 T-Cell Responses following Coimmunization with Plasmids Expressing the Dominant pp89 and Subdominant M84 Antigens of Murine Cytomegalovirus Correlate with Long-Term Protection against Subsequent Viral Challenge
J. Virol., March 1, 2002; 76(5): 2100 - 2112.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
R. Holtappels, N. K. A. Grzimek, D. Thomas, and M. J. Reddehase
Early gene m18, a novel player in the immune response to murine cytomegalovirus
J. Gen. Virol., February 1, 2002; 83(2): 311 - 316.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Holtappels, D. Thomas, J. Podlech, and M. J. Reddehase
Two Antigenic Peptides from Genes m123 and m164 of Murine Cytomegalovirus Quantitatively Dominate CD8 T-Cell Memory in the H-2d Haplotype
J. Virol., January 1, 2002; 76(1): 151 - 164.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. G. Kavanagh, U. H. Koszinowski, and A. B. Hill
The Murine Cytomegalovirus Immune Evasion Protein m4/gp34 Forms Biochemically Distinct Complexes with Class I MHC at the Cell Surface and in a Pre-Golgi Compartment
J. Immunol., October 1, 2001; 167(7): 3894 - 3902.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Holtappels, J. Podlech, N. K. A. Grzimek, D. Thomas, M.-F. Pahl-Seibert, and M. J. Reddehase
Experimental Preemptive Immunotherapy of Murine Cytomegalovirus Disease with CD8 T-Cell Lines Specific for ppM83 and pM84, the Two Homologs of Human Cytomegalovirus Tegument Protein ppUL83 (pp65)
J. Virol., July 15, 2001; 75(14): 6584 - 6600.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2000 by the Society for General Microbiology.